Drugs / Chicken type II collagen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001614 | Jul 1997 → May 2000 | juvenile idiopathic arthritis, uveitis | National Eye Institute (NEI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chicken type II collagen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001614 ↗ |
| Known as | Colloral | “Chicken type II collagen (Colloral) is being developed as an oral tolerance therapy for the treatment of rheumatoid arthritis.” NCT00001614 ↗ |
| Route | Oral | “Chicken type II collagen (Colloral) is being developed as an oral tolerance therapy” NCT00001614 ↗ |